Healios

Healios operates in digital healthcare, with a particular focus on online mental-health care and remote autism and ADHD services for children, families, and adults in the UK. Its described model combines clinician-delivered care with remote appointments, diagnostic support, and digital resources. Products include the Panacea Online Clinical Platform and ThinkNinja, a CBT-informed app for young people aged 10–18. The company also describes NHS partnerships and private and workplace support options. Its recorded categories—Health Care, Hospital, and Medical—are broad, so they do not establish a precise competitive set. The clearest points of distinction in its offering are its combination of specialist neurodevelopmental services and mental-health support, its intended reach across age groups, and its digital delivery alongside clinical expertise. The available profile lists 251–500 employees and $28.5 million in total funding across three rounds, but does not provide comparable figures for competitors.

Healios’s funding history shows a progression from a £2.2 million venture round on Jun 14, 2018 to a £7 million Series A on May 18, 2021, followed by a £14 million Series B on Nov 3, 2022. These rounds total approximately $28.5 million using the recorded USD amounts. A separate hiring signal notes that Healios announced more than 200 roles in early 2023, suggesting a significant recruitment push at that time, but the current workforce is only given as a broad 251–500 range and there is no updated hiring plan. Its listed portfolio spans online mental-health services, autism and ADHD assessment and support, the Panacea platform, and ThinkNinja. The Oct 10, 2025 feature indicates continued visibility in mental-health innovation coverage, but does not establish a new product launch or measurable commercial expansion.